Fundraising Fox

Biotech Investors & VC Firms in North America

272 firms in this list, with a median first check of $500K. 65 of them lead rounds. Generated from verified public data and updated continuously.

Joyance Partners
BerlinPre-Seed–Series A
35 people
Norwest Venture Partners
Menlo ParkSeed–Late Stage
4 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
61 people
Anzu Partners
BillericaPre-Seed–Growth
44 people
OUP (Osage University Partners)
Bala CynwydSeed–Late Stage$1M – $20M
22 people
PharmStars Ventures
BostonPre-Seed–Seed
24 people
Giant Ventures Global Llp
LondonPre-Seed–Late Stage
30 people
Illumina Ventures
Foster CityPre-Seed–Late Stage
38 people
OMERS Ventures
TorontoPre-Seed–Series B$3.6M – $18.3M
18 people
Hitachi Ventures
MunichSeed–Series B
25 people
Hatteras Venture Partners
Research TriangleSeed–Series C$500K – $4M
20 people
Advent Life Sciences
LondonSeed–Late Stage
26 people
Optum Ventures
BostonSeed–Late Stage
30 people
Taiwania Capital
TaipeiSeed–Growth$3M – $85M
42 people
Versant Ventures
San FranciscoSeed–Late Stage$250K – $5M
36 people
Capricorn Venture Partners
LeuvenSeed–Late Stage$270K – $10.8M
29 people
Two Bear Capital
WhitefishPre-Seed–Series B$3M – $10M
37 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
35 people
MPM BioImpact
BostonPre-Seed–Series C$1M – $15M
35 people
AgFunder
San FranciscoSeed–Growth
31 people
Rev1 Ventures
ColumbusPre-Seed–Series A
43 people
Lightstone Ventures
Portola ValleyPre-Seed–Late Stage
28 people
Prime Movers Lab
JacksonSeed–Growth
28 people
Atlantic Bridge Ventures
DublinSeed–Late Stage$1M – $5M
31 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.